Article
The oncogenic CCDC6-RET fusion product is a dual ATP and ADP-dependent kinase that…
medRxiv · 2025 · Martin-Hurtado, A.; Contreras, J. C.; Sanchez-Wandelmer, J.; Zarzuela, E.; Munoz, I. G.; Munoz, J.; Isasa, M.; Plaza-Menacho, I.
Key facts
| Title | The oncogenic CCDC6-RET fusion product is a dual ATP and ADP-dependent kinase that functions via cis-phosphorylation |
|---|---|
| First author | Martin-Hurtado, A.; Contreras, J. C.; Sanchez-Wandelmer, J.; Zarzuela, E.; Munoz, I. G.; Munoz, J.; Isasa, M.; Plaza-Menacho, I. |
| Journal | medRxiv |
| Published | Jan 1, 2025 |
| DOI | 10.1101/2025.01.14.632894 |
| Devices mentioned | K973350, K990827 |
| Product codes mentioned | JLX, KQP |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1